[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 6 - The Spring Supplement of Shefaye Khatam 1 - ::
Shefaye Khatam 2018, 6 - The Spring Supplement of Shefaye Khatam 1 -: 73-73 Back to browse issues page
P42: The Effects of Vitamin A on Inflammatory Factors (CCL2, CCL18, CD14) in Multiple Sclerosis
Mohammad Rahneshin * , Sajjad Sahab Negah
Neuroscience Department, Mashhad University of Medical Sciences, Mashhad, Iran , rahneshin.mohammad@gmail.com
Abstract:   (2724 Views)

Multiple Sclerosis (MS) is a complex neurological disease in which neuro inflammation that leads to neurodegeneration _ plays a key role and its prevalence is 2 million in the world. Vitamin A is a fat-soluble vitamin that is multifunctional. One of the important functions is in immune system, both in immunological tolerance and in adaptive immune responses. 264 patients will be enrolled that suffer from MS and divided them into two groups. Group (A) will take interferon beta and Vitamin A and group (B) will take interferon beta and placebo. we will follow them for one year and every six months we will check the inflammatory factors in the serum. In this project, we expect that vitamin A regulate CCL2 (as a chemokine) which means vitamin A will increases amount of CCL2 in serum and then CCL2 will effect on TH cells (stimulate TH2 and TReg) and then IL-10 that is anti-inflammatory cytokine will increase and IL-2 that is pro-inflammatory cytokine will be inhibited by IL-10. We guess if vitamin A increases the amount of CCL2 about 50 pg/ml we can see the expected changes. Based on other researches, we expect that vitamin A regulate the inflammatory factors and then reduce the rate and intensity of relapsing in patients.

Keywords: Multiple Sclerosis, Vitamin A, Helper T Cells
Full-Text [PDF 242 kb]   (608 Downloads)    
Type of Study: Research --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rahneshin M, Sahab Negah S. P42: The Effects of Vitamin A on Inflammatory Factors (CCL2, CCL18, CD14) in Multiple Sclerosis. Shefaye Khatam 2018; 6 (S1) :73-73
URL: http://shefayekhatam.ir/article-1-1640-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6 - The Spring Supplement of Shefaye Khatam 1 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 45 queries by YEKTAWEB 4645